Filter
1897
Filtered Results: 1897
Text search:
therapeutics
committees
Featured
Recommendations
228
New Publications
508
Language
Document type
No document type
1027
Guidelines
312
Studies & Reports
300
Manuals
114
Strategic & Response Plan
72
Training Material
25
Situation Updates
21
Fact sheets
18
Resource Platforms
4
Brochures
2
Infographics
2
Countries / Regions
India
93
Global
73
South Africa
71
Kenya
65
Ethiopia
50
Uganda
45
Sierra Leone
38
Nigeria
36
Western and Central Europe
35
Ghana
30
Nepal
29
Liberia
27
Namibia
24
Rwanda
22
Latin America and the Carribbean
22
Zambia
22
Malawi
21
Bangladesh
21
Africa
19
Tanzania
19
Zimbabwe
18
Germany
18
Myanmar / Burma
18
Congo, Democratic Republic of
16
Lesotho
15
Philippines
15
South Sudan
14
Mozambique
13
Burkina Faso
12
Syria
11
South–East Asia Region
11
Indonesia
11
Guinea
9
Cambodia
9
West and Central Africa
9
East and Southern Africa
9
Eastern Europe
9
Brazil
9
Eswatini/ Swaziland
9
Ukraine
8
Haiti
8
Asia
8
Russia
8
Eastern Europe and Central Asia
7
Pakistan
7
Cameroon
6
Middle East and North Africa
6
Botswana
6
Iraq
5
Colombia
4
Thailand
4
Afghanistan
4
USA
4
Sudan
4
Yemen
4
Central African Republic
4
Benin
3
China
3
Fiji
3
Laos
3
Burundi
3
Vietnam
3
Mali
3
Tajikistan
2
Serbia
2
Albania
2
Singapore
2
Senegal
2
Uzbekistan
2
Armenia
2
Venezuela
2
Lithuania
2
Jordan
2
Western Pacific Region
2
Gabon
2
Mauritius
2
United Kingdom
2
Sri Lanka
2
Poland
2
Angola
2
Libya
2
Bhutan
2
Madagascar
2
North Macedonia
1
Gambia
1
Kazakhstan
1
Chile
1
Iran
1
Estonia
1
Kyrgyzstan
1
Niger
1
Peru
1
Malaysia
1
Bulgaria
1
Guinea-Bissau
1
Hungary
1
Paraguay
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Belarus
1
Southern Africa
1
Argentina
1
Papua New Guinea
1
Egypt
1
Romania
1
Georgia
1
Chad
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
763
Clinical Guidelines
182
Public Health
103
Key Resources
103
Women & Child Health
95
Pharmacy & Technologies
26
Capacity Building
20
Toolboxes
Mental Health
165
COVID-19
155
AMR
150
Pharmacy
107
HIV
90
TB
76
Rapid Response
59
Ebola & Marburg
54
NTDs
54
Caregiver
53
NCDs
42
Conflict
42
Disability
39
Refugee
28
Natural Hazards
23
Global Health Education
18
Planetary Health
17
Health Financing Toolbox
16
Social Ethics
9
Zika
9
Polio
9
Specific Hazards
7
Cholera
6
Malaria
3
The previous report of the WHO Expert Committee on this disease
followed a meeting in 1995. Intensive, coordinated efforts against HAT during
the intervening 18 years have resulted in a decrease in incidence to a point at
which elimination is considered feasible. This report provides informati...
with recommended essential medicines for common diseases in patients in Stockholm County Council (Healthcare Region), Sweden
These guidelines are based on the 3rd Edition of the WHO Guidelines (Published 2015) World Health Organization’s Guidelines for the treatment of malaria. Additional literature surveys have been undertaken. Factors that were considered in the choice of therapeutic options included effectiveness, sa...
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
The publication of the Second Edition of the Emergency Drug Guidelines represents the culmination of the efforts of the National Drugs and Therapeutics Committee (NDTC) to publish clinical drug guidelines for common diseases seen in Fiji. These guidelines are targeted for health care professionals w...
The PHC STGs and EML should be used by healthcare workers providing care at clinics, community health centres, and gateway clinics at hospitals.
Pharmaceutical and Therapeutics Committees (PTCs) are responsible for ensuring the availability of medicines listed in the PHC EML at those facilities, as...
Asthma is a heterogeneous condition characterised by chronic inflammation and variable expiratory airflow limitation, as well as airway reversibility. The diagnosis of asthma in young children is limited by the inability to perform objective lung function testing in this group of patients and the wi...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il...
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an ...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for...
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi...
Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to ident...
Antimicrobial resistance represents a big threat to public health. The Centers for Disease Control and Prevention (CDC) estimate that every year two million Americans are infected with a (multi-)drug resistant bacterium, resulting in 23,000 deaths. The WHO has repeatedly drawn attention to this majo...
